Korean Air Lines Co will present a 1.5 trillion self-rescue plan in return for a 1.2 trillion financial support from two state lenders.
The plan includes a 1 trillion won stock offering.
The Korea Development Bank (KDB) and the Export-Import Bank of Korea (Exim Bank) had announced that they would inject 1.2 trillion won into Korean Air to ease the impact of the pandemic.
The amount consists of 200 billion won operating capital to Korean Air for a purchase of 700 billion won worth of securities 300 billion won in perpetual bonds convertible into stocks.
The perpetual bonds with no maturity date could be converted into Korean Air stocks and get a 10.8 percent stake in the carrier.
Korean Air will sell non-core assets and had 70 percent of its 20,000 workforces take paid leaves for six months as part of its self-rescue plan.
Most international flights have been suspended by local airlines due to entry restrictions triggered by the coronavirus.


Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Google Secures Pentagon AI Deal for Classified Projects
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 



